![]() The global Skin Excision Market size is expected to reach USD 59.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.9% from 2022 to 2030. The market expansion of skin excision is primarily caused by the rising elderly population, rising obesity incidence, and rising aesthetic consciousness. The skin excision method has changed over a short period due to expanding demand, rising discretionary income, growing awareness, and adoption of cosmetic procedures, technological improvement in the devices used for surgeries, advancements in drugs and therapies, availability of qualified surgeons, and improved healthcare facilities. Skin excision is a procedure in which excess skin is removal removed and people who lose a lot of weight through weight loss surgery or lifestyle changes opt for such treatment as their skin becomes loose and sags. There are various types of procedures for excess skin removal including Brachioplasty, Mastopexy, Rhytidectomy, Thigh lift, Neck Lift, Brow lift, Abdominoplasty, etc. These procedures are carried out at hospitals and clinics where board-certified surgeons perform such skin excision procedures. People have become more conscious about their personalities and appearances with major influence from social media. To overcome body flaws because of aging, pregnancy, heredity, or high BMI, people opt for reconstructive surgeries. The ratio of females appearing for surgery seems to be higher than males. For instance, according to ISAPS report 2020, 92.0% of the total procedures of abdominoplasty (Tummy Tuck) were performed on females which were approximately 703,778 in number. The demand for skin excision procedures shrank in 2020 due to the outbreak of COVID as global restrictions and lockdown were imposed in most countries initially, and many non-cosmetic surgical procedures were halted. However, ISAPS reported, that the willingness to opt for invasive as well as non-invasive treatments globally has increased post-pandemic. Related Press Release@ Skin Excision Market Report List of Key Players in the Skin Excision Market
Brachioplasty Market Lip Augmentation Market Skin Excision Market Report ScopeReport Attribute Details Market size value in 2022 USD 29.9 billion Revenue forecast in 2030 USD 59.0 billion Growth Rate CAGR of 8.9% from 2022 to 2030 Base year for estimation 2021 Historical data 2018 - 2020 Forecast period 2022 - 2030 Skin Excision Market Segmentation Grand View Research has segmented the global skin excision market based on procedure type, end-use, and region: Skin Excision Procedure Type Outlook (Revenue, USD Million, 2018 - 2030)
0 Comments
![]() The global Cellular Immunotherapy Market size is expected to reach USD 37.97 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 22.41% during the forecast period, driven by the growing government support for innovative therapies research, rising prevalence of cancer, development of advanced cell-based immunotherapies, and increasing R&D investment by global players. Growing support from government organizations and research institutes including the National Cancer Institute (NCI) and Center of Excellence in Immunology (CEI) for cellular immunotherapies research is one of the major factors driving the market growth. For instance, the CEI pulls out experts from other institutes such as NCI and NIH to promote the growth of immunotherapy for the treatment of cancer. Also, the Surgery Branch of the National Cancer Institute's Center for Cancer Research (CCR) is committed to the innovation of novel immunotherapies for the treatment of cancer patients. The rising number of M&As, collaborations, acquisitions, and funding is a major trend observed in the market. M&A and collaboration help companies expand their existing product portfolio and regional reach in a short period. For instance, in March 2021, TrakCel received funding from Labcorp and AmerisourceBergen for cellular therapy orchestration research and global expansion. Also, in April 2020, Kite (a Gilead Company) and Teneobio, Inc. entered into a license agreement through which Kite will receive exclusive rights to specific antibodies targeted to B-cell maturation antigen (BCMA). Thus, such M&A and collaborations are expected to boost the market growth. A substantial number of cellular immunotherapy companies are engaged in new product launches, pertaining to licensing, collaborations, & acquisitions, and regional expansion. Some of the key companies in the market are Bristol-Myers Squibb Company; Novartis AG; Gilead Sciences Inc. (Kite Pharma); F. Hoffmann-La Roche Ltd.; and Johnson & Johnson. These companies are adopting various business models to gain a competitive advantage. For instance, in February 2021, Novartis secured approval for the first Australian commercial CAR-T manufacturing site for Kymriah. With this approval, the company would be able to develop Kymriah in Australia, thereby providing easy access to Australian patients. The COVID-19 pandemic has had a high impact on the market. Owing to stringent regulations to curb the pandemic, a slowdown in clinical trials, approval of new drugs, and delayed cancer diagnosis have been observed, affecting the industry's growth amid the pandemic. However, in several countries, the effect of COVID-19 declined after the third quarter of 2021, which helped the market regain traction. Related Press Release@ Cellular Immunotherapy Market Report List of Key Players in the Cellular Immunotherapy Market
Details Market size value in 2022 USD 7.5 billion Revenue forecast in 2030 USD 37.97 billion Growth Rate CAGR of 22.41% from 2022 to 2030 Base year for estimation 2021 Historical data 2018 - 2020 Forecast period 2022 - 2030 Related Reports@ T-cell Therapy Market Cell Therapy Market Cellular Immunotherapy Market Segmentation Grand View Research has segmented the global cellular immunotherapy market based on therapy type, indication, end-use, and region: Cellular Immunotherapy Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)
|
Archives
October 2023
|